Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rohto-Mentholatum (Vietnam) is a leading subsidiary of the Japanese Rohto Pharmaceutical Co., Ltd., established in 1996. The company specializes in the manufacture and distribution of pharmaceutical products, cosmetics, and consumer healthcare goods, maintaining a dominant position in the Vietnamese over-the-counter (OTC) market. Its extensive portfolio includes iconic brands such as V.Rohto eye drops, LipIce lip care, Sunplay sunscreen, and Acnes skincare treatments. Operating a state-of-the-art manufacturing facility in Binh Duong, the company adheres to international standards including GMP-WHO, GMP-ASEAN, and ISO 13485. Rohto-Mentholatum (Vietnam) is also recognized for its significant contributions to community health through nationwide eye care and dermatology programs. The company continues to innovate in topical drug delivery and high-quality skincare solutions for the Southeast Asian region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rohto-Mentholatum (Vietnam).